BioCentury
ARTICLE | Company News

Norgine, Valeant Pharmaceuticals deal

August 22, 2016 7:00 AM UTC

Norgine granted Valeant rights to develop and commercialize NER1006, an osmotic low-volume polyethylene glycol laxative, in the U.S. and Canada. Norgine will manufacture and supply the product to Val...